Lifecore Biomedical (Lifecore Biomedical) EBIT per Share : $-1.69 (TTM As of May. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical EBIT per Share?

Lifecore Biomedical's EBIT per Share for the three months ended in May. 2023 was $-0.84. Its EBIT per Share for the trailing twelve months (TTM) ended in May. 2023 was $-1.69.

During the past 3 years, the average EBIT per Share Growth Rate was -29.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Lifecore Biomedical's EBIT per Share or its related term are showing as below:

LFCR' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -36 Med: 6.6 Max: 88
Current: -29.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Lifecore Biomedical was 88.00% per year. The lowest was -36.00% per year. And the median was 6.60% per year.

LFCR's 3-Year EBIT Growth Rate is ranked worse than
88.15% of 852 companies
in the Drug Manufacturers industry
Industry Median: 7.95 vs LFCR: -29.40

Lifecore Biomedical's EBIT for the three months ended in May. 2023 was $-25.4 Mil.

Lifecore Biomedical EBIT per Share Historical Data

The historical data trend for Lifecore Biomedical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical EBIT per Share Chart

Lifecore Biomedical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

EBIT per Share

Get a 7-Day Free Trial

0.31

-0.89

-0.71

-0.17

-1.55

Lifecore Biomedical Quarterly Data
	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23
EBIT per Share	Get a 7-Day Free Trial															-0.07	-0.26	-0.28	-0.32	-0.84

Lifecore Biomedical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Lifecore Biomedical's EBIT per Share for the fiscal year that ended in May. 2023 is calculated as

	EBIT per Share		(A: May. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-46.279	/	29.958
=	-1.54

Lifecore Biomedical's EBIT per Share for the quarter that ended in May. 2023 is calculated as

	EBIT per Share		(Q: May. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-25.359	/	30.318
=	-0.84

EBIT per Share for the trailing twelve months (TTM) ended in May. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.69

Lifecore Biomedical (NAS:LFCR) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Lifecore Biomedical EBIT per Share Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecore Biomedical (Lifecore Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3515 Lyman Boulevard, Chaska, MN, USA, 55318

Website

https://www.lifecore.com

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid.

Executives

Raymond T. White	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Christopher S Kiper	director	12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway	director	C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Wynnefield Partners Small Cap Value Lp I	10 percent owner	450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Raymond H Diradoorian	director	C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter	director	C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh	director	14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg	officer: Chief Financial Officer	C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles	director	CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall	officer: Executive Vice President	3515 LYMAN BLVD., CHASKA MN 55318